We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

85 hedge funds and large institutions have $439M invested in Intellia Therapeutics in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 17

63% more capital invested

Capital invested by funds: $269M → $439M (+$170M)

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

2.29% more ownership

Funds ownership: 46.66% → 48.95% (+2.3%)

0% more funds holding

Funds holding: 85 → 85 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

58% less call options, than puts

Call options by funds: $1.55M | Put options by funds: $3.71M

Holders
85
Holders Change
–
Holders Change %
0%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
34
Reduced
17
Closed
13
Calls
$1.55M
Puts
$3.71M
Net Calls
-$2.16M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
GTP
Global Thematic Partners
New York
+$9.46M
2
GC
GMT Capital
Georgia
+$6.23M
3
AIM
ARK Investment Management
Florida
+$3.72M
4
Northern Trust
Northern Trust
Illinois
+$2.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$904K

Top Sellers

Rank Fund Capital Flow
1
AVAI
Atlas Venture Associates IX
Massachusetts
-$2.83M
2
AG
Artal Group
Luxembourg
-$1.41M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.19M
4
OAM
Oxford Asset Management
United Kingdom
-$1.13M
5
SM
Sabby Management
Florida
-$918K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$953K -$584K -31,010 -45%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$891K +$391K +20,748 +137%
MAM
28
Martingale Asset Management
Massachusetts
$803K +$609K +32,307 New
Goldman Sachs
29
Goldman Sachs
New York
$794K -$313K -16,602 -34%
AllianceBernstein
30
AllianceBernstein
Tennessee
$673K -$62.2K -3,300 -11%
Bank of America
31
Bank of America
North Carolina
$657K +$21K +1,113 +4%
TA
32
Teachers Advisors
New York
$648K +$452 +24 +0.1%
CS
33
Credit Suisse
Switzerland
$585K +$443K +23,538 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$580K -$33.9K -1,800 -7%
AQR Capital Management
35
AQR Capital Management
Connecticut
$563K +$191K +10,137 +81%
ProShare Advisors
36
ProShare Advisors
Maryland
$530K +$29.6K +1,569 +8%
Swiss National Bank
37
Swiss National Bank
Switzerland
$514K – – –
NI
38
Numeric Investors
Massachusetts
$508K +$385K +20,434 New
MWVC
39
Morgens Waterfall Vintiadis & Co
New York
$497K +$377K +20,000 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$434K +$5.46K +290 +2%
Wells Fargo
41
Wells Fargo
California
$415K -$254K -13,498 -45%
Citadel Advisors
42
Citadel Advisors
Florida
$348K +$264K +14,010 New
PIMJS
43
PKO Investment Management Joint-Stock
Poland
$318K +$113K +6,000 +88%
MSAM
44
Moloney Securities Asset Management
Missouri
$306K +$232K +12,296 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$304K -$18.1K -962 -7%
M&T Bank
46
M&T Bank
New York
$286K – – –
Creative Planning
47
Creative Planning
Kansas
$284K +$159K +8,415 +281%
Commonwealth Equity Services
48
Commonwealth Equity Services
Massachusetts
$281K +$10.1K +536 +5%
SM
49
Sabby Management
Florida
$280K -$918K -48,719 -81%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$274K – – –
1
2
3 4

NTLA Hedge Fund Activity: Q3 2017 in Review

85 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q3 2017, worth a combined $439M — up 63% from $269M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NTLA positions and 13 closed out — a net gain of 2 holders — while 34 added to existing stakes and 17 trimmed.

The largest buyer was Global Thematic Partners, opening a new position worth an estimated $9.46M. The largest seller was Atlas Venture Associates IX, cutting an estimated $2.83M.

  • 85 institutional investors held Intellia Therapeutics (NTLA) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $439M of Intellia Therapeutics stock for Q3 2017, up 63% quarter-over-quarter.
  • 15 funds opened new Intellia Therapeutics positions in Q3 2017 and 13 closed out, a net change of +2 holders.
  • The largest Intellia Therapeutics buyer in Q3 2017 was Global Thematic Partners, an estimated $9.46M added.
  • The largest Intellia Therapeutics seller in Q3 2017 was Atlas Venture Associates IX, an estimated $2.83M sold.

Based on aggregated 13F filings for Q3 2017.